| 1. | Erythrocyte deformability is altered under various pathophysiological conditions.
|
| 2. | Some deformability tests may be more physiologically-relevant than others for given applications.
|
| 3. | The viscoelasticity of the blood is dominated by the deformability of the red blood cells.
|
| 4. | The resulting origami battery achieves significant linear and areal deformability, large twistability and bendability.
|
| 5. | Deformability of the erythrocytes that cause the microcirculatory distress can be demonstrated through various other hemorheological characteristics.
|
| 6. | Both pathways result in membrane loss, decreased surface area, and formation of spherocytes with decreased deformability.
|
| 7. | Erythrocyte deformability is an important determinant of blood viscosity, hence blood flow resistance in the vascular system.
|
| 8. | The influence of aggregation properties on the viscoelasticity diminish and the influence of red cell deformability begins to increase.
|
| 9. | Sickle-cell disease is characterized by extensive impairment in erythrocyte deformability, being dependent on the oxygen partial pressure.
|
| 10. | Moreover, some tests may track how deformability itself changes as conditions change and / or as deformation is repeated.
|